{"id":"NCT03572049","sponsor":"University of Alabama at Birmingham","briefTitle":"Endemic Mycoses Treatment With SUBA-itraconazole vs Itraconazole","officialTitle":"SUBA-itraconazole Versus Conventional Itraconazole in the Treatment of Endemic Mycoses: a Multi-center, Open-label Comparative Trial","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2018-09-17","primaryCompletion":"2021-05-31","completion":"2022-04-29","firstPosted":"2018-06-28","resultsPosted":"2022-10-06","lastUpdate":"2023-07-07"},"enrollment":88,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Invasive Fungal Infections"],"interventions":[{"type":"DRUG","name":"SUBA itraconazole","otherNames":[]},{"type":"DRUG","name":"Conventional itraconazole","otherNames":["itraconazole","Sporanox"]}],"arms":[{"label":"SUBA itraconazole","type":"EXPERIMENTAL"},{"label":"Conventional itraconazole","type":"ACTIVE_COMPARATOR"}],"summary":"This is a prospective, multi-center, randomized, open-label parallel arm study involving patients with proven or probable invasive endemic fungal infection to ascertain the pharmacokinetics, safety, efficacy, tolerability and health economics of oral SUBA-itraconazole compared to conventional itraconazole. Patients will receive randomized open-label study drug (SUBA-itraconazole or conventional itraconazole) over a 42 day period and then continue therapy until Day 180. Patients will be stratified based on clinically reported infection with the human immunodeficiency virus (HIV).","primaryOutcome":{"measure":"Comparison of Plasma Itraconazole Levels and Hydroxyitraconazole Levels at Day 14","timeFrame":"Day 14","effectByArm":[{"arm":"SUBA Itraconazole","deltaMin":60.5,"sd":null},{"arm":"Conventional Itraconazole","deltaMin":71,"sd":null}],"pValues":[]},"eligibility":{"minAge":"19 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":12,"countries":["United States","Panama"]},"refs":{"pmids":["38440302","32457106"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":42},"commonTop":["Edema","Hypertension","Diarrhea","Nausea","Headache"]}}